⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

January 1, 2012Journal of Cardiovascular Magnetic ResonanceOpen Access

Diffuse myocardial fibrosis evaluation using cardiac magnetic resonance T1 mapping: sample size considerations for clinical trials

View Full Paper

Ask AI

Bookmark

Share

Authors

SLSongtao LiuXuzhou Central Hospital JHJing HanBeijing Language and Culture University MNMarcelo Souto NacifUniversidade Federal Fluminense

Discussion

Loading...

Member takes

Implication

May inform CMR trial endpoint selection; leaves open clinical adoption pending prospective validation.

Structured PICO

I

Intervention

Cardiac magnetic resonance T1 mapping (ECV and λ quantification)

O

Outcome

Variability across scanssurrogate

ECV and λ quantification via CMR T1 mapping have low variability across scans, making them viable tools for evaluating clinical trial outcomes.

Cite This Study

Liu et al. (2012) studied this question.

synapsesocial.com/papers/69da297eba6014a02e8366a7 https://doi.org/10.1186/1532-429x-14-90

Topics

Heart failure HFrEF treatment

View Full Paper

Ask AI

Bookmark

Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

1Modified Look‐Locker inversion recovery (MOLLI) for high‐resolution <i>T</i><sub>1</sub> mapping of the heart2004 · 1,374 citations
2Assessment of myocardial viability using MRI during a constant infusion of Gd-DTPA: Further studies at early and late periods of reperfusion1999 · 67 citations
3Variability in Absolute Apparent Diffusion Coefficient Values across Different Platforms May Be Substantial: A Multivendor, Multi-institutional Comparison Study2008 · 307 citations
4Human Myocardium: Single-Breath-hold MR T1 Mapping with High Spatial Resolution—Reproducibility Study2006 · 239 citations